PCR amplification, using primers located in the kinase domain of ALK, confirmed the presence of ALK in our resistant cells and in EML4-ALK positive lung cancer cells, which served as a positive control (Additional file 3: Figure S3A). The gene discussed is EML4; the disease is lung cancer.